However, true to its hormone-regulated non-malignant ancestor, prostate cancer cells remain dependent on a ligand-activated androgen receptor (AR) to facilitate mitogenic responses enabled by genomic aberration. The gene discussed is AR; the disease is prostate carcinoma.